OraSure Technologies PE Ratio 2010-2023 | OSUR
Current and historical p/e ratio for OraSure Technologies (OSUR) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. OraSure Technologies PE ratio as of May 15, 2024 is 12.82.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| OraSure Technologies PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-15 | 5.39 | 7.48 | |
| 2023-12-31 | 8.20 | $0.72 | 11.39 |
| 2023-09-30 | 5.93 | $0.66 | 8.98 |
| 2023-06-30 | 5.01 | $0.58 | 8.64 |
| 2023-03-31 | 6.05 | $0.39 | 15.51 |
| 2022-12-31 | 4.82 | $-0.26 | 0.00 |
| 2022-09-30 | 3.79 | $-0.61 | 0.00 |
| 2022-06-30 | 2.71 | $-0.89 | 0.00 |
| 2022-03-31 | 6.78 | $-0.65 | 0.00 |
| 2021-12-31 | 8.69 | $-0.32 | 0.00 |
| 2021-09-30 | 11.31 | $-0.15 | 0.00 |
| 2021-06-30 | 10.14 | $0.07 | 144.86 |
| 2021-03-31 | 11.67 | $-0.07 | 0.00 |
| 2020-12-31 | 10.59 | $-0.24 | 0.00 |
| 2020-09-30 | 12.17 | $-0.23 | 0.00 |
| 2020-06-30 | 11.63 | $-0.03 | 0.00 |
| 2020-03-31 | 10.76 | $0.20 | 53.80 |
| 2019-12-31 | 8.03 | $0.27 | 29.74 |
| 2019-09-30 | 7.47 | $0.39 | 19.15 |
| 2019-06-30 | 9.28 | $0.31 | 29.94 |
| 2019-03-31 | 11.15 | $0.31 | 35.97 |
| 2018-12-31 | 11.68 | $0.33 | 35.39 |
| 2018-09-30 | 15.45 | $0.29 | 53.28 |
| 2018-06-30 | 16.47 | $0.25 | 65.88 |
| 2018-03-31 | 16.89 | $0.27 | 62.56 |
| 2017-12-31 | 18.86 | $0.51 | 36.98 |
| 2017-09-30 | 22.50 | $0.52 | 43.27 |
| 2017-06-30 | 17.26 | $0.54 | 31.96 |
| 2017-03-31 | 12.93 | $0.52 | 24.87 |
| 2016-12-31 | 8.78 | $0.35 | 25.09 |
| 2016-09-30 | 7.97 | $0.30 | 26.57 |
| 2016-06-30 | 5.91 | $0.22 | 26.86 |
| 2016-03-31 | 7.23 | $0.18 | 40.17 |
| 2015-12-31 | 6.44 | $0.14 | 46.00 |
| 2015-09-30 | 4.44 | $0.01 | 0.00 |
| 2015-06-30 | 5.39 | $-0.00 | 0.00 |
| 2015-03-31 | 6.54 | $0.01 | 0.00 |
| 2014-12-31 | 10.14 | $-0.09 | 0.00 |
| 2014-09-30 | 7.22 | $0.07 | 103.14 |
| 2014-06-30 | 8.61 | $0.02 | 430.50 |
| 2014-03-31 | 7.97 | $-0.12 | 0.00 |
| 2013-12-31 | 6.29 | $-0.20 | 0.00 |
| 2013-09-30 | 6.01 | $-0.42 | 0.00 |
| 2013-06-30 | 3.88 | $-0.43 | 0.00 |
| 2013-03-31 | 5.40 | $-0.40 | 0.00 |
| 2012-12-31 | 7.18 | $-0.29 | 0.00 |
| 2012-09-30 | 11.11 | $-0.18 | 0.00 |
| 2012-06-30 | 11.24 | $-0.22 | 0.00 |
| 2012-03-31 | 11.49 | $-0.20 | 0.00 |
| 2011-12-31 | 9.11 | $-0.19 | 0.00 |
| 2011-09-30 | 7.96 | $-0.21 | 0.00 |
| 2011-06-30 | 8.53 | $-0.12 | 0.00 |
| 2011-03-31 | 7.86 | $-0.08 | 0.00 |
| 2010-12-31 | 5.75 | $-0.07 | 0.00 |
| 2010-09-30 | 4.05 | $-0.11 | 0.00 |
| 2010-06-30 | 4.63 | $-0.08 | 0.00 |
| 2010-03-31 | 5.93 | $-0.18 | 0.00 |
| 2009-12-31 | 5.08 | $-0.17 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.398B | $0.405B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Medtronic (MDT) | Ireland | $112.493B | 15.93 |
| Boston Scientific (BSX) | United States | $109.225B | 34.79 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| Haemonetics (HAE) | United States | $4.900B | 24.24 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| ICU Medical (ICUI) | United States | $2.546B | 22.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |